2022 Archives - Philogen Spa

Philogen to attend the Antibody Engineering & Therapeutics on December 4-8, 2022 in San Diego

Dec 3, 2022 | 2022, Events

Philogen announces its attendance at the Antibody Engineering & Therapeutics 2022. Prof. Dario Neri, CEO and CSO of Philogen, is giving a lecture entitled “Small Molecule-drug Conjugates (SMDCs) and Antibody-drug Conjugates (ADCs): A Comparative Evaluation” Please...

Philogen to attend Melanoma Bridge in Naples, 1-3 December 2022

Dec 3, 2022 | 2022, Events

Philogen is Sponsor at the 13th edition of Melanoma Bridge in Naples, 1-3 December 2022. For further details

Philogen provides corporate update

Dec 1, 2022 | 2022, Press Releases, Scientific

The management team to hold a Webinar on Dec 1, 2022, at 10:00 ET / 15:00 GMT / 16:00 CET (Please find the link for the webinar here). Corporate_Update_Dec 1

28 novembre 2022 – Aggiornamento sul programma di acquisto di azioni proprie

Nov 28, 2022 | 2022, Investors, Press Releases

More details

21 novembre 2022 – Aggiornamento sul programma di acquisto di azioni proprie

Nov 21, 2022 | 2022, Investors, Press Releases

More details

Philogen announces publication in Protein Science on the selection and structural characterization of a novel PD-1 blocking antibody

Nov 18, 2022 | 2022, Press Releases, Scientific

The study describes the development of a novel anti-PD-1 antibody that shows potent blockade of PD-1 with a different recognition mechanism compared to anti-PD-1 antibodies that have recently reached the market. For more details